Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.

Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.

Item
http://www.wikidata.org/entity/Q50502530
Adjuvant chemotherapy for early female breast cancer: a systematic review of the evidence for the 2014 Cancer Care Ontario systemic therapy guidelineResistance and escape from antiangiogenesis therapy: clinical implications and future strategiesSOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancer.Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).Delayed triggering of oestrogen induced apoptosis that contrasts with rapid paclitaxel-induced breast cancer cell death.Re-visiting Hypersensitivity Reactions to Taxanes: A Comprehensive Review.Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.CREATE-X a role for capecitabine in early-stage breast cancer: an analysis of available data.Interpreting febrile neutropenia rates from randomized, controlled trials for consideration of primary prophylaxis in the real world: a systematic review and meta-analysis.Not too big, not too small: a goldilocks approach to sample size selection.A Multicenter Phase II Trial of Neoadjuvant Chemotherapy with Docetaxel and Gemcitabine in Locally Advanced Breast Cancer.
P2860

Phase III trial evaluating weekly paclitaxel versus docetaxel in combination with capecitabine in operable breast cancer.

Item
http://www.wikidata.org/entity/Q50502530
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Phase III trial evaluating wee ...... ine in operable breast cancer.
@en
Phase III trial evaluating wee ...... ine in operable breast cancer.
@nl
type
label
Phase III trial evaluating wee ...... ine in operable breast cancer.
@en
Phase III trial evaluating wee ...... ine in operable breast cancer.
@nl
prefLabel
Phase III trial evaluating wee ...... ine in operable breast cancer.
@en
Phase III trial evaluating wee ...... ine in operable breast cancer.
@nl
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921
P356
P1433
P1476
Phase III trial evaluating wee ...... ine in operable breast cancer.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P921